title: Intravitreal bevacizumab for iris tumor metastasized from large cell neuroendocrine carcinoma of lung.
authors.affiliation: Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan, yokouchi123@peace.ocn.ne.jp.
authors.forename: Hirotaka
authors.initials: H
authors.lastname: Yokouchi
authors.forename: Masayasu
authors.initials: M
authors.lastname: Kitahashi
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Oshitari
authors.forename: Shuichi
authors.initials: S
authors.lastname: Yamamoto
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D018278:Carcinoma, Neuroendocrine / Q000098:blood supply / Q000188:drug therapy* / Q000556:secondary; D005451:Fluorescein Angiography; D006801:Humans; D007429:Intraocular Pressure; D058449:Intravitreal Injections; D015811:Iris Neoplasms / Q000098:blood supply / Q000188:drug therapy* / Q000556:secondary; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab